Bloomberg Reports on Challenges of Bringing New HIV Drugs to Market
March 15, 2011
"Three decades after the discovery of the virus that causes AIDS, there are 31 drugs on the market that have helped turn HIV from a death sentence into a manageable disease in the developed world. Only six were approved after 2004," Bloomberg reports in an article examining the challenges drug developers face in bringing new HIV drugs to market. The article describes how higher standards for new antiretroviral drugs, longer clinical trials, and fewer available clinical trial participants are combining to slow drug development and fuel experts' concerns that "millions of HIV patients face the possibility of the virus becoming fatal again if it shifts shape inside cells to outsmart existing therapies," according to the news service (Cortez, 3/14).
J&J Will Not Join Medicines Patent Pool; Company's Pharma Head Says Mechanism Could "Cause Disaster"
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)